INTERNATIONAL BIOTECHNOLOGY TRUST PLC - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 177 filers reported holding BLUEBIRD BIO INC in Q4 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.0%.

Quarter-by-quarter ownership
INTERNATIONAL BIOTECHNOLOGY TRUST PLC ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q3 2021$210,000
-40.2%
11,0000.0%0.05%
-45.2%
Q2 2021$351,000
+5.7%
11,0000.0%0.09%
+5.7%
Q1 2021$332,000
-30.3%
11,0000.0%0.09%
-32.3%
Q4 2020$476,000
-19.7%
11,0000.0%0.13%
-31.9%
Q3 2020$593,000
-10.2%
11,0000.0%0.19%
-12.8%
Q2 2020$660,000
+30.7%
11,0000.0%0.22%
-4.8%
Q1 2020$505,000
-66.1%
11,000
-35.3%
0.23%
-57.2%
Q4 2019$1,491,000
-4.5%
17,0000.0%0.54%
-25.5%
Q3 2019$1,561,000
-27.8%
17,0000.0%0.72%
-10.1%
Q2 2019$2,163,000
-19.1%
17,0000.0%0.80%
-18.8%
Q1 2019$2,675,000
+102.0%
17,0000.0%0.99%
+20.2%
Q4 2018$1,324,000
-30.4%
17,0000.0%0.82%
-9.1%
Q3 2018$1,903,000
-39.3%
17,000
-15.0%
0.90%
-25.0%
Q2 2018$3,137,000
-8.1%
20,0000.0%1.20%
-9.5%
Q1 2018$3,413,000
-4.1%
20,0000.0%1.33%
+6.1%
Q4 2017$3,560,000
+29.6%
20,0000.0%1.26%
+17.4%
Q3 2017$2,746,00020,0001.07%
Other shareholders
BLUEBIRD BIO INC shareholders Q4 2021
NameSharesValueWeighting ↓
Monashee Investment Management LLC 125,000$13,131,0005.55%
Cormorant Asset Management, LP 275,000$28,889,0004.79%
Eventide Asset Management 569,700$59,847,0003.73%
Crosspoint Capital Strategies, LLC 28,937$3,040,0002.66%
Casdin Capital, LLC 65,000$6,828,0002.53%
ARK Investment Management 119,683$12,573,0002.45%
RTW INVESTMENTS, LP 104,383$10,965,0002.31%
Taylor Wealth Management Partners 38,368$4,031,0001.82%
First Light Asset Management, LLC 33,780$3,549,0001.19%
Atika Capital Management LLC 25,000$2,627,0000.92%
View complete list of BLUEBIRD BIO INC shareholders